Showing 3391-3400 of 20414 results for "".
Diagnosis of Internal Disease Through Dermatology
https://reachmd.com/programs/clinicians-roundtable/diagnosis-of-internal-disease-through-dermatology/336/The Skin. What secrets does the largest organ of the body hold?Investigating the Potential Link Between Epstein-Barr Virus & MS
https://reachmd.com/programs/frontlines-multiple-sclerosis/investigating-the-potential-link-between-epstein-barr-virus-ms/13542/A new study has found evidence that the Epstein-Barr virus may trigger multiple scleroris. Here's what we know so far.The Mental Health Impacts of a Pandemic: Recapping a Survey of Healthcare Workers
https://reachmd.com/programs/covid-19-frontlines/the-mental-health-impacts-of-a-pandemic-recapping-a-survey-of-healthcare-workers/13680/How has the COVID-19 pandemic affected the mental health of those on the frontlines? Here’s a look at the data.Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
https://reachmd.com/programs/neurofrontiers/novel-mechanisms-in-schizophrenia-guidelines/36641/Schizophrenia treatment has long centered on D2 receptor antagonism, but is that still enough? With novel, mechanism-based therapies now available, such as muscarinic agonists, TAAR1 agonists, and glutamate modulators, the case for modernizing current guidelines is growing stronger. Joining Dr. CharProbiotics in GI Practice: Evidence, Guidelines, and Emerging Innovations
https://reachmd.com/programs/gi-insights/probiotics-in-gi-practice-evidence-guidelines-and-emerging-innovations/36495/Probiotic use in gastroenterology remains a complex and evolving topic, shaped by variable evidence and growing patient demand. Dr. Peter Buch sits down with Dr. Alexa Weingarden to review current data, discuss distinctions between probiotic-related therapies, and explore the clinical utilityDiagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
https://reachmd.com/programs/living-rheum/diagnosing-long-covid-rheumatologic-implications-of-2024-criteria/32816/Diagnosing long COVID continues to pose challenges for clinicians and patients alike. While 2024 diagnostic criteria from the National Academies aimed to make navigating it easier, the framework may raise some concerns, particularly for rheumatologists. Hear Ryan Quigley break down a commentary on tReal-World Impact of Deucravacitinib in Psoriasis Care
https://reachmd.com/programs/clinicians-roundtable/real-world-impact-of-deucravacitinib-in-psoriasis-care/36365/Racial Disparities in Atopic Dermatitis Care: Improving Education, Access, and Research
https://reachmd.com/programs/dermconsult/racial-disparities-in-atopic-dermatitis-care-improving-education-access-and-research/29445/Learn about the challenges of managing atopic dermatitis in diverse populations and how we can address them.Insights on Nephrology: Key Abstracts From Kidney Week 2022
https://reachmd.com/programs/asn-action-center/insights-nephrology-key-abstracts-kidney-week-2022/14612/Learn more about the latest in kidney care from a collection of abstracts presented at Kidney Week 2022.Improve Heart Failure Today: A Global Call to Action
https://reachmd.com/programs/video-library/improve-heart-failure-today-a-global-call-to-action/12081/Worldwide patients with heart failure are receiving suboptimal pharmacologic care. Evidence-based medicine provides us with a roadmap for addressing treatable causes of heart failure. We are asking our colleagues to consider how they can ensure every patient is receiving the care they need.